Neonatal alloimmune thrombocytopenia due to HPA‐9b incompatibility
Pediatric Blood & Cancer2009Vol. 53(3), pp. 459–461
Citations Over Time
Abstract
Neonatal alloimmune thrombocytopenia (NAIT) is one of the most frequent causes of both severe thrombocytopenia and intracranial hemorrhage (ICH) in fetuses and term neonates. The diagnosis is established by demonstrating antibodies against human platelet antigens (HPA) and discordance in platelet antigen typing between parents or between the mother and neonate. We report a case of NAIT that was likely due to maternal sensitization to HPA-9b (Max(a)), a recently recognized, rare platelet-specific antigen.
Related Papers
- → Prophylactic administration of HPA-1a–specific antibodies prevents fetal/neonatal alloimmune thrombocytopenia in mice(2022)13 cited
- → Fetal and neonatal alloimmune thrombocytopenia(2012)11 cited
- → Neonatal alloimmune thrombocytopenia due to anti-HPA-5b (Br a )(2003)9 cited
- → Triplets with neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1a(2016)
- → Fetal and Neonatal Alloimmune Thrombocytopenia(2020)